Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program

Published:2017-11 Issue: Volume:62 Page:168-174
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Das Sonya,Lo Andrew W.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference45 articles.

1. Innovation in the pharmaceutical industry: new estimates of R&D costs;DiMasi;J. Health Econ.,2016

2. Drug development and clinical trials—the path to an approved cancer drug;Rubin;Nat. Rev. Clin. Oncol.,2012

3. Nonprofit biomedical companies;Conti;Clin. Pharmacol. Ther.,2008

4. Clinical development success rates for investigational drugs;Hay;Nat. Biotechnol.,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial;Nature Medicine;2024-09-14

2. What Fusion Energy Can Learn From Biotechnology;SSRN Electronic Journal;2024

3. Evidence-based medicine: new in the search for evidence;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-10-19

4. Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy;Cancer Cell;2023-09

5. Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations;Statistical Science;2023-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP